Neuroplasticity

Neuroplasticity is the brain's capacity to physically reorganize itself — forming new connections, strengthening or pruning existing ones, and in limited regions generating new cells — in response to experience, learning, injury, or chemical change.

The term covers several distinct processes. Synaptic plasticity adjusts the signalling strength between neurons. Structural plasticity reshapes the physical branches neurons extend toward one another. And in a handful of regions, including the hippocampus, neurogenesis introduces new neurons into existing circuits. Together these processes allow the adult brain to keep adapting rather than remaining fixed after development.

How it works · its role

The central principle is that neurons which fire together tend to wire together: repeated co-activation between two cells strengthens the synapse between them, while inactivity weakens it. These changes are formalised as long-term potentiation (LTP), which increases synaptic efficiency, and long-term depression (LTD), which reduces it.

A key molecular driver is brain-derived neurotrophic factor (BDNF), a protein that promotes neuronal growth and the formation of new synaptic contacts. NMDA receptors — a subtype of glutamate receptor — act as coincidence detectors: they trigger LTP only when two neurons fire at nearly the same moment, making them central to the cellular machinery of learning and memory.

Relevance to substances & effects

Several substance classes are thought to promote neuroplasticity, and researchers increasingly link this to both their therapeutic promise and their risks. Classic psychedelics such as psilocybin and LSD appear to drive rapid growth of dendritic spines — the tiny protrusions through which neurons receive signals. This structural effect is one proposed mechanism behind their potential in treating depression and PTSD.

Ketamine produces fast-acting antidepressant effects partly by activating BDNF pathways through AMPA signalling, bypassing the slower synaptic changes associated with traditional antidepressants. The endocannabinoid system, targeted by cannabis, is itself a modulator of synaptic plasticity, particularly at synapses in the hippocampus and prefrontal cortex.

Neuroplasticity also underpins the maladaptive changes that accompany chronic substance use. Repeated stimulant exposure, for example, remodels reward circuits in ways that strengthen drug-seeking behaviour and weaken prefrontal control over impulse. Tolerance to many substances involves a related process: receptors downregulate or desensitise, and compensatory synaptic changes shift the brain's baseline so that more of a substance is needed to produce the same effect.